Cargando…
Changes in soluble tumor necrosis factor receptor type 1 levels and early renal function decline in patients with diabetes
The relationship between serial changes in soluble tumor necrosis factor receptor type 1 (TNFR1) levels and an early decline in estimated glomerular filtration rate (eGFR) decline remains to be defined. We found that in patients with an early decline in renal function (n = 30), soluble TNFR1 values...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6825941/ https://www.ncbi.nlm.nih.gov/pubmed/30989829 http://dx.doi.org/10.1111/jdi.13061 |
_version_ | 1783464981808807936 |
---|---|
author | MacIsaac, Richard J Farag, Matthew Obeyesekere, Varuni Clarke, Michele Boston, Ray Ward, Glenn M Jerums, George Ekinci, Elif I |
author_facet | MacIsaac, Richard J Farag, Matthew Obeyesekere, Varuni Clarke, Michele Boston, Ray Ward, Glenn M Jerums, George Ekinci, Elif I |
author_sort | MacIsaac, Richard J |
collection | PubMed |
description | The relationship between serial changes in soluble tumor necrosis factor receptor type 1 (TNFR1) levels and an early decline in estimated glomerular filtration rate (eGFR) decline remains to be defined. We found that in patients with an early decline in renal function (n = 30), soluble TNFR1 values increased (2,595 ± 683 vs 3,596 ± 1,203 pg/mL, P < 0.001) as eGFR decreased (89 ± 1 vs 51 ± 2 mL/min/1.73m(2), P < 0.001) over an 8‐year period. In contrast, there were no significant changes in soluble TNFR1 levels in patients with stable renal function (n = 17). In a multilevel mixed effects regression model, changes in soluble TNFR1 levels were found to be independently associated with eGFR decline (Z = −4.31, P < 0.001). An early decline in eGFR is associated with an increase in soluble TNFR levels; however, the factors driving this increase and the possible pathological role that soluble TNFR1 plays in progressive diabetic kidney disease remain to be determined. |
format | Online Article Text |
id | pubmed-6825941 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-68259412019-11-07 Changes in soluble tumor necrosis factor receptor type 1 levels and early renal function decline in patients with diabetes MacIsaac, Richard J Farag, Matthew Obeyesekere, Varuni Clarke, Michele Boston, Ray Ward, Glenn M Jerums, George Ekinci, Elif I J Diabetes Investig Articles The relationship between serial changes in soluble tumor necrosis factor receptor type 1 (TNFR1) levels and an early decline in estimated glomerular filtration rate (eGFR) decline remains to be defined. We found that in patients with an early decline in renal function (n = 30), soluble TNFR1 values increased (2,595 ± 683 vs 3,596 ± 1,203 pg/mL, P < 0.001) as eGFR decreased (89 ± 1 vs 51 ± 2 mL/min/1.73m(2), P < 0.001) over an 8‐year period. In contrast, there were no significant changes in soluble TNFR1 levels in patients with stable renal function (n = 17). In a multilevel mixed effects regression model, changes in soluble TNFR1 levels were found to be independently associated with eGFR decline (Z = −4.31, P < 0.001). An early decline in eGFR is associated with an increase in soluble TNFR levels; however, the factors driving this increase and the possible pathological role that soluble TNFR1 plays in progressive diabetic kidney disease remain to be determined. John Wiley and Sons Inc. 2019-06-03 2019-11 /pmc/articles/PMC6825941/ /pubmed/30989829 http://dx.doi.org/10.1111/jdi.13061 Text en © 2019 The Authors. Journal of Diabetes Investigation published by Asian Association for the Study of Diabetes (AASD) and John Wiley & Sons Australia, Ltd This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Articles MacIsaac, Richard J Farag, Matthew Obeyesekere, Varuni Clarke, Michele Boston, Ray Ward, Glenn M Jerums, George Ekinci, Elif I Changes in soluble tumor necrosis factor receptor type 1 levels and early renal function decline in patients with diabetes |
title | Changes in soluble tumor necrosis factor receptor type 1 levels and early renal function decline in patients with diabetes |
title_full | Changes in soluble tumor necrosis factor receptor type 1 levels and early renal function decline in patients with diabetes |
title_fullStr | Changes in soluble tumor necrosis factor receptor type 1 levels and early renal function decline in patients with diabetes |
title_full_unstemmed | Changes in soluble tumor necrosis factor receptor type 1 levels and early renal function decline in patients with diabetes |
title_short | Changes in soluble tumor necrosis factor receptor type 1 levels and early renal function decline in patients with diabetes |
title_sort | changes in soluble tumor necrosis factor receptor type 1 levels and early renal function decline in patients with diabetes |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6825941/ https://www.ncbi.nlm.nih.gov/pubmed/30989829 http://dx.doi.org/10.1111/jdi.13061 |
work_keys_str_mv | AT macisaacrichardj changesinsolubletumornecrosisfactorreceptortype1levelsandearlyrenalfunctiondeclineinpatientswithdiabetes AT faragmatthew changesinsolubletumornecrosisfactorreceptortype1levelsandearlyrenalfunctiondeclineinpatientswithdiabetes AT obeyesekerevaruni changesinsolubletumornecrosisfactorreceptortype1levelsandearlyrenalfunctiondeclineinpatientswithdiabetes AT clarkemichele changesinsolubletumornecrosisfactorreceptortype1levelsandearlyrenalfunctiondeclineinpatientswithdiabetes AT bostonray changesinsolubletumornecrosisfactorreceptortype1levelsandearlyrenalfunctiondeclineinpatientswithdiabetes AT wardglennm changesinsolubletumornecrosisfactorreceptortype1levelsandearlyrenalfunctiondeclineinpatientswithdiabetes AT jerumsgeorge changesinsolubletumornecrosisfactorreceptortype1levelsandearlyrenalfunctiondeclineinpatientswithdiabetes AT ekincielifi changesinsolubletumornecrosisfactorreceptortype1levelsandearlyrenalfunctiondeclineinpatientswithdiabetes |